Filing Details

Accession Number:
0001595585-19-000266
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-26 19:09:23
Reporting Period:
2019-11-22
Accepted Time:
2019-11-26 19:09:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1595585 Tricida Inc. TCDA Pharmaceutical Preparations (2834) 463372526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1744280 I Sandra Coufal 7000 Shoreline Court
Suite 201
South San Francisco CA 94080
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-22 48,030 $40.53 2,906,184 No 4 S Indirect By Sibling Capital Fund II-B L.P.
Common Stock Disposition 2019-11-22 132,834 $41.17 2,773,350 No 4 S Indirect By Sibling Capital Fund II-B L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Sibling Capital Fund II-B L.P.
No 4 S Indirect By Sibling Capital Fund II-B L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 777,411 Indirect By Sibling Capital Fund II-A L.P.
Common Stock 1,810,195 Indirect By Sibling Capital Fund II-C L.P.
Common Stock 599,379 Indirect By Sibling Capital Fund II-D L.P.
Common Stock 463,158 Indirect By Sibling Insiders Fund II L.P.
Common Stock 6,480 Indirect By Coufal Irrevocable Trust
Common Stock 217,652 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 to $40.89, inclusive. The Reporting Person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (4) to this Form 4.
  2. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person disclaims beneficial ownership of any such securities, except to the extent of pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
  3. The shares are held directly by Sibling Capital Fund II-B L.P. ("Sibling B"). Sibling Capital Ventures II LLC ("SCV II") is the sole general partner of Sibling B. As co-manager of SCV II, Sandra I. Coufal may be deemed to be an indirect beneficial owner of such shares.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.90 to $41.61, inclusive.
  5. The shares are held directly by Sibling Capital Fund II-A L.P. ("Sibling A"). Sibling Capital Ventures LLC ("SCV") is the sole general partner of Sibling A. As co-manager of SCV, Sandra I. Coufal may be deemed to be an indirect beneficial owner of such shares.
  6. The shares are held directly by Sibling Capital Fund II-C L.P. ("Sibling C"). Sibling Capital Ventures III LLC ("SCV III") is the sole general partner of Sibling C. As co-manager of SCV III, Sandra I. Coufal may be deemed to be an indirect beneficial owner of such shares.
  7. The shares are held directly by Sibling Capital Fund II-D L.P. ("Sibling D"). Sibling Capital Ventures IV LLC ("SCV IV") is the sole general partner of Sibling D. As co-manager of SCV IV, Sandra I. Coufal may be deemed to be an indirect beneficial owner of such shares.
  8. The shares are held directly by Sibling Insiders Fund II L.P. ("Sibling Insiders Fund"). Sibling Insiders II LLC ("Sibling Insiders LLC") is the sole general partner of Sibling Insiders Fund. As co-manager of Sibling Insiders LLC, Sandra I. Coufal may be deemed to be an indirect beneficial owner of such shares.
  9. The spouse of the Reporting Person is the sole trustee of the Coufal Irrevocable Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Coufal Irrevocable Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.